Abstract
Single 600-mg capsules of rifampin were given orally to 26 patients as prophylaxis during cardiac valve replacement. Antibiotic concentrations were measured in blood (serum or plasma) and tissue (excised cardiac valve). The serum or plasma levels of rifampin in 18 patients who ingested this drug 2 h before they received preoperative opiates and anticholinergics intramuscularly were not significantly different from the levels in four normal volunteers who received the drug. These levels were 15.9 +/- 6.5 micrograms/ml (mean +/- standard deviation) 2 h after drug administration, 7.1 +/- 4.3 micrograms/ml 8 h after drug administration and 2 h after a mean of 1.4 h on cardiopulmonary bypass, and 1.6 +/- 1.6 micrograms/ml 24 h after drug ingestion. The valve tissue level was 3.8 +/- 2.7 micrograms/g (mean +/- standard deviation; n = 10). This value was 65% of the simultaneous serum and plasma levels and 31% of the peak serum and plasma levels. Eight patients who were given rifampin at the same time that they received other preoperative medications had significantly lower blood levels than the 18 patients who received rifampin 2 h earlier (P less than 0.001). No rifampin was detected in valves from seven of these patients. Decreased rifampin absorption due to simultaneous administration with opiates and anticholinergics was the probable reason for the low plasma and serum levels observed. These data suggest that, if properly dosed, rifampin administered orally gives high blood and valve tissue levels, which are affected minimally by cardiopulmonary bypass in patients undergoing cardiac valve surgery.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Acocella G. Clinical pharmacokinetics of rifampicin. Clin Pharmacokinet. 1978 Mar-Apr;3(2):108–127. doi: 10.2165/00003088-197803020-00002. [DOI] [PubMed] [Google Scholar]
- Archer G. L. Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices. Antimicrob Agents Chemother. 1978 Sep;14(3):353–359. doi: 10.1128/aac.14.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Archer G. L., Vazquez G. J., Johnston J. L. Antibiotic prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. J Infect Dis. 1980 Nov;142(5):725–731. doi: 10.1093/infdis/142.5.725. [DOI] [PubMed] [Google Scholar]
- Burks T. F. Gastrointestinal pharmacology. Annu Rev Pharmacol Toxicol. 1976;16:15–31. doi: 10.1146/annurev.pa.16.040176.000311. [DOI] [PubMed] [Google Scholar]
- Joiner K. A., Lowe B. R., Dzink J. L., Bartlett J. G. Antibiotic levels in infected and sterile subcutaneous abscesses in mice. J Infect Dis. 1981 Mar;143(3):487–494. doi: 10.1093/infdis/143.3.487. [DOI] [PubMed] [Google Scholar]
- Lecaillon J. B., Febvre N., Metayer J. P., Souppart C. Quantitative assay of rifampicin and three of its metabolites in human plasma, urine and saliva by high-performance liquid chromatography. J Chromatogr. 1978 Mar 1;145(2):319–324. doi: 10.1016/s0378-4347(00)81356-0. [DOI] [PubMed] [Google Scholar]
- Polk R. E., Archer G. L., Lower R. Cefamandole kinetics during cardiopulmonary bypass. Clin Pharmacol Ther. 1978 Apr;23(4):473–480. doi: 10.1002/cpt1978234473. [DOI] [PubMed] [Google Scholar]
- STEIGMANN F., KAMINSKI L. Belladonna alkaloid-sedative mixture; effects on gastric acidity and motility. Am J Dig Dis. 1956 Apr;1(4):174–189. doi: 10.1007/BF02233476. [DOI] [PubMed] [Google Scholar]
- Vazquez G. J., Archer G. L. Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis. Antimicrob Agents Chemother. 1980 Feb;17(2):280–285. doi: 10.1128/aac.17.2.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zilly W., Breimer D. D., Richter E. Pharmacokinetic interactions with rifampicin. Clin Pharmacokinet. 1977 Jan-Feb;2(1):61–70. doi: 10.2165/00003088-197702010-00005. [DOI] [PubMed] [Google Scholar]